永顺生物(839729) - 投资者关系活动记录表

Group 1: Investor Relations Activity - The company participated in the "2023 Guangdong Listed Companies Investor Online Reception Day" on September 19, 2023 [1][2] Group 2: Company Performance and Market Outlook - The management is closely monitoring the potential for transferring to the Beijing Stock Exchange and will disclose any plans in accordance with regulations [3] - The overall pig prices remain low, and the industry is still undergoing capacity reduction, making future performance uncertain [4] - The company’s production capacity utilization is currently high, and there is stability in orders for Q4 and next year [5] Group 3: Product and Market Information - The company offers over 30 types of animal biological products, including vaccines for pigs, poultry, and aquatic animals, with core products ranking highly in market share [6] - Export sales reached 6.95 million yuan in the first half of the year, a 58.64% increase compared to the same period last year, with a focus on expanding into markets like Egypt [7] - The company is actively researching and developing vaccines for African swine fever [8]